How Long Does a TAVR Procedure Take?

A transfemoral TAVR, the most common approach today, typically takes about an hour of actual procedural time. One study comparing two access routes reported average procedure times of roughly 58 minutes regardless of whether the valve was delivered through the leg or the shoulder area.¹ That said, the clock can stretch well beyond an hour depending on the complexity of the case, the team’s experience, and how things go once the catheter is inside. The full picture of how long the process takes, from pre-procedure workup to walking out of the hospital, involves a much wider window than the time spent in the procedure room.

What Happens During Those 60 Minutes

TAVR replaces a diseased aortic valve without opening the chest. In the most common version, the team threads a catheter through the femoral artery in the groin, guides it up to the heart under live X-ray imaging, and positions a new valve inside the old one. Once seated, the replacement valve begins working immediately. The old valve’s leaflets get pushed aside rather than removed.

The procedural time typically includes gaining arterial access, advancing the catheter and guidewire, positioning and deploying the valve, checking for leaks or problems with imaging and hemodynamic measurements, and closing the access site. Each step is guided by fluoroscopy, the real-time X-ray that lets the team see exactly where everything is. Reported fluoroscopy times at experienced centers have dropped to under 10 minutes in some programs, down from an average of about 18 to 19 minutes earlier in their experience.² That improvement mirrors a broader trend: as teams refine their workflow, nearly every measurable step gets shorter.

How the Access Route Affects Duration

Transfemoral access, through the large artery in the groin, is the default approach and generally the fastest. When the femoral arteries are too small, too calcified, or too tortuous, alternative routes include the subclavian or axillary artery near the shoulder, the carotid artery in the neck, or the transapical approach, which requires a small incision between the ribs to access the heart directly.

When researchers compared transfemoral and subclavian access using the same self-expanding valve, they found no meaningful difference in procedure time, with both averaging about 58 minutes.¹ Transapical TAVR, however, has historically taken considerably longer. Data from the early PARTNER-I trial showed mean transapical procedure times of about 120 minutes.³ That longer duration partly reflects the era: transapical cases were performed in TAVR’s earlier years, on patients who could not receive transfemoral access, and often by teams still building experience. Today transapical TAVR is relatively rare, but if your team recommends it, expect more time on the table.

Fluoroscopy exposure also varies by route. Patients receiving transapical TAVR tend to accumulate less fluoroscopy time than transfemoral patients, likely because the catheter path is shorter and more direct.⁴ That might sound counterintuitive given the longer total procedure time, but it reflects the fact that much of the extra time in transapical cases is spent on surgical access and wound closure rather than catheter manipulation under X-ray.

The Learning Curve and Why Your Center’s Experience Matters

TAVR procedure times shrink as a hospital’s team gains experience, sometimes dramatically. The PARTNER-I transapical data showed procedure times falling from about 131 minutes in a center’s earliest cases to around 116 minutes by the thirtieth case, then leveling off near 117 minutes.³ That plateau suggests the biggest efficiency gains come early, as teams develop their choreography and iron out logistical hiccups.

A more striking illustration comes from fluoroscopy times. One high-volume center reported cutting its transfemoral fluoroscopy time from an average of about 18.5 minutes down to roughly 8.6 minutes as it refined its workflow over a thousand cases.² That halving of imaging time reflects not just faster hands but also better standardized protocols, fewer unnecessary imaging runs, and smoother coordination between the interventional cardiologist, anesthesia team, and imaging technicians.

For you as a patient, this means the center you choose can meaningfully affect how long you spend in the procedure room and how much radiation you receive. High-volume programs tend to deliver shorter, more streamlined procedures, and asking about a center’s annual TAVR volume is a reasonable question at your consultation.

When the Procedure Takes Longer Than Usual

Several anatomical and clinical scenarios push procedure times higher. Valve-in-valve TAVR, where a new transcatheter valve is placed inside a previously implanted surgical or transcatheter valve that has worn out, takes longer than a first-time procedure. One comparison found valve-in-valve cases averaged about 87 minutes versus about 76 minutes for standard native-valve TAVR.⁵ The extra time comes from the added complexity of positioning a new valve precisely within the old frame, which can require more careful imaging and subtle adjustments.

Bicuspid aortic valves, where the valve has two leaflets instead of the usual three, also present challenges. The asymmetric opening and heavier calcium deposits make positioning trickier and technical failure more likely. In patients with small aortic annuli, those with bicuspid valves had roughly double the rate of technical failure compared with patients who had the standard three-leaflet anatomy.⁶ A technical failure does not always mean a dramatically longer procedure, but it can involve repositioning attempts, additional imaging, or even conversion to a different approach, all of which add time.

Heavy aortic calcification, extremely tortuous blood vessels, and a very horizontal aorta can also slow things down. These are factors your team evaluates during pre-procedure imaging, and they are part of why the planning phase before TAVR is so thorough.

Sedation Versus General Anesthesia

The choice between moderate sedation (sometimes called conscious sedation, where you are drowsy but not fully unconscious) and general anesthesia affects the overall timeline in the procedure room, though the core procedural steps remain the same. General anesthesia adds time for induction, intubation, and emergence, and it typically requires transesophageal echocardiography, an ultrasound probe placed in the esophagus that gives detailed images of the heart during the procedure. Sedation-based cases often rely on transthoracic echocardiography or fluoroscopy alone, which speeds setup and recovery within the room.

There is genuine disagreement in the field about which approach is best. Some centers use general anesthesia for nearly all cases; others have moved almost entirely to conscious sedation.⁷ The debate persists partly because the evidence base is limited, and partly because strong preferences exist among anesthesiologists, cardiologists, and surgeons. From a time perspective, sedation-based TAVR generally means less total time in the procedure suite and a faster initial recovery, though neither approach changes the core valve-deployment time itself.

The Workup Before the Procedure

If you are focused on the total timeline from “my doctor says I need a valve replacement” to “the valve is replaced,” the pre-procedure planning phase is a significant chunk. TAVR requires extensive imaging to map the aortic valve, measure the annulus, evaluate the access arteries, and plan the exact valve size and deployment strategy. A CT scan of the chest, abdomen, and pelvis is standard. Many patients also undergo echocardiography, coronary angiography, and sometimes additional vascular imaging.

TAVR patients tend to undergo more pre-procedural testing than those headed for traditional open-heart surgery. One study found that TAVR patients averaged about six cardiac specialist encounters and roughly two cardiac imaging events before the procedure, compared to about four specialist encounters and one imaging event for surgical valve replacement patients.⁸ That extra workup reflects the precision required for catheter-based delivery: the team needs to know exactly what size valve will fit, which artery to use, and whether any anatomical surprises lie along the route. The tradeoff is a longer lead-up but a much less invasive procedure day.

Hospital Stay and Same-Day Discharge

In the early era of TAVR, hospital stays of a week or more were common. The PARTNER-I transapical data showed a median post-procedure stay of eight days, though that shortened with increasing institutional experience.³ Today, many transfemoral TAVR patients go home the next day, and a growing number are discharged on the same day as the procedure.

Same-day discharge after TAVR has been studied in multiple settings and appears safe for carefully selected patients. A multicenter study (the PROTECT TAVR study) concluded that same-day discharge was safe and feasible in patients at low risk for post-discharge complications.⁹ A separate analysis of national data from 2015 to 2019 found that patients discharged the same day had similar 30-day readmission rates to those who stayed longer, at about 10% versus 9%, with no increase in major vascular complications, heart failure episodes, or stroke.¹⁰ Additional single-center work has confirmed the feasibility of same-day discharge pathways for transfemoral cases without impairing safety.¹¹

Not everyone qualifies for same-day discharge. Patients who need a new pacemaker after the procedure, those who experience significant vascular complications at the access site, and those with unstable hemodynamics or new conduction abnormalities will stay longer. But for a straightforward transfemoral case in a patient without complications, the realistic timeline from arrival to departure can be measured in hours rather than days.

Functional Recovery in the Months After

The procedure itself may take an hour, but recovery to your baseline function takes longer, and the trajectory varies widely. A study tracking functional status over the year following valve replacement found that after TAVR, the most common recovery pattern was “fair,” meaning a moderate dip in function at one month with gradual but incomplete improvement. About a quarter of patients had “good” trajectories, returning close to their pre-procedure function by three months. Roughly 14% had “excellent” recovery, and a similar share had “poor” trajectories where function declined at one month and stayed down.¹²

Those numbers are worth framing carefully. TAVR patients in this study were older and sicker than surgical patients, which partly explains why their functional trajectories were less favorable overall. The comparison is not apples to apples: TAVR was initially reserved for patients too frail for open surgery, so a “fair” recovery in a high-risk TAVR patient might represent a genuinely good outcome given where they started. The key takeaway is that while you will feel the benefit of the new valve relatively quickly in terms of reduced breathlessness and fatigue, full functional recovery is a matter of weeks to months, not days. Patients who had the best outcomes tended to see a dip at one month, then return to their pre-procedure level by around three months with little change after that.

Radiation Exposure During TAVR

Because the entire procedure is guided by fluoroscopy, both patients and the procedural team are exposed to ionizing radiation. The risks range from localized skin effects to longer-term concerns. Strategies to minimize exposure include lowering the fluoroscopy pulse rate, using protective shielding, and reducing the total imaging time.² Published fluoroscopy times for “minimalist” TAVR protocols, where the team consciously streamlines imaging use, range from about 18 to 28 minutes at various centers. The most experienced programs have pushed that figure well below those benchmarks.

Radiation exposure is not typically something patients have much control over, but it is another reason center experience matters. A team that has refined its imaging protocols over hundreds or thousands of cases will generally expose you to less radiation than a team still climbing the learning curve. If you have had multiple prior fluoroscopic or CT procedures and are concerned about cumulative exposure, it is reasonable to ask about the center’s typical fluoroscopy times.

Why Published Times Vary So Much

If you search for TAVR procedure times, you will find numbers ranging from under an hour to over two hours. This is not contradictory; it reflects the wide range of patient populations, access routes, valve types, eras, and definitions of “procedure time” across different studies. Some studies clock the time from arterial puncture to skin closure. Others include the full time in the procedure room, which adds anesthesia induction and emergence. A few older studies lump in time spent on balloon aortic valvuloplasty or other preparatory steps.

The difference between eras is also real. A transapical case performed in 2011 as part of an early clinical trial bears little resemblance to a transfemoral case performed in 2024 at a high-volume center using current-generation devices, conscious sedation, and a streamlined workflow. Today’s typical transfemoral TAVR at an experienced center is closer to 45 to 75 minutes of actual procedure time, though complications or unusual anatomy can extend that. The best advice is to ask your own team what they typically expect for your specific case. They will have the clearest picture based on your anatomy, access route, and their own institutional experience.